PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, a leading provider of life sciences procurement and supplier management SaaS solutions, today announced its acquisition by Waud Capital Partners (“Waud Capital”), a growth-oriented middle-market private equity firm specializing in the software & technology and healthcare sectors.

加利福尼亚州帕洛阿尔托（商业新闻短讯）--生命科学采购和供应商管理SaaS解决方案的领先提供商科学交易所今天宣布，其收购对象为Waud Capital Partners（“Waud Capital”），这是一家专注于软件、技术和医疗保健领域的增长型中等市场私人股本公司。

This acquisition marks a significant milestone in Science Exchange’s journey and will compound the company’s impressive performance, growth trajectory, and software capabilities. The partnership with Waud Capital will enable the company to accelerate its mission to transform the purchasing and supplier orchestration landscape for life sciences organizations..

此次收购标志着科学交易所（Science Exchange）发展历程中的一个重要里程碑，将巩固该公司令人印象深刻的业绩、增长轨迹和软件能力。与Waud Capital的合作将使该公司加快其使命，为生命科学组织转变采购和供应商协调格局。。

Waud Capital’s strategic acquisition comes after a thorough evaluation of the life sciences procurement technology market, during which Science Exchange separated itself as a standout leader. The company is distinguished by its innovative, modern cloud supplier orchestration platform, delivered through a transparent SaaS subscription model.

Waud Capital的战略收购是在对生命科学采购技术市场进行全面评估之后进行的，在此期间，科学交易所将自己分离为杰出的领导者。该公司以其创新的现代云供应商协调平台而著称，该平台通过透明的SaaS订阅模式提供。

The platform digitizes procurement workflows, including initial supplier and product discovery, contracting and compliance management, RFP management, purchase and change orders, internal approvals, spend and pricing intelligence, and invoicing and payment. The solution has rapidly gained traction among the scientists and procurement teams of top global pharmaceutical companies and biotech organizations as it drives substantial cost savings, streamlines supplier collaboration, and accelerates project execution..

该平台将采购工作流程数字化，包括初始供应商和产品发现、合同和合规管理、RFP管理、采购和变更单、内部批准、支出和定价情报以及发票和付款。该解决方案在全球顶尖制药公司和生物技术组织的科学家和采购团队中迅速获得了吸引力，因为它可以节省大量成本，简化供应商合作，并加速项目执行。。

“With Waud Capital’s support, we are poised to further solidify our position as the premier SaaS supplier orchestration platform in the life sciences industry,” said Elizabeth Iorns, Ph.D., CEO & Co-Founder of Science Exchange. “Our platform has already transformed how life sciences companies work with their suppliers, and this partnership will enable us to accelerate our product innovation, drive even faster growth, and expand our impact across the industry.

“在Waud Capital的支持下，我们准备进一步巩固我们作为生命科学行业首屈一指的SaaS供应商协调平台的地位，”Science Exchange首席执行官兼联合创始人Elizabeth Iorns博士表示。“我们的平台已经改变了生命科学公司与其供应商的合作方式，这种合作关系将使我们能够加速产品创新，推动更快的增长，并扩大我们在整个行业的影响力。

Waud’s proven track record in scaling technology companies, combined with their deep experience in healthcare and life sciences, makes them the ideal partner to help us unlock the next phase of Science Exchange's evolution. I am excited to work closely with the Waud team to broaden our offerings, deliver unparalleled value to our customers, and ultimately, help bring therapeutics to market more efficiently and effectively.”.

Waud在规模化技术公司方面的良好记录，加上他们在医疗保健和生命科学方面的丰富经验，使他们成为帮助我们开启科学交流下一阶段发展的理想合作伙伴。我很高兴能与Waud团队密切合作，扩大我们的产品范围，为客户提供无与伦比的价值，并最终帮助更有效地将治疗药物推向市场。”。

“Waud Capital’s acquisition of Science Exchange is a testament to the strength of their technology and the leadership team’s vision,” said Matthew Clary, Partner at Waud Capital. “This partnership combines our experience investing in software, HCIT, and pharma services and aligns perfectly with our strategy of investing behind strong leaders with differentiated solutions in attractive end markets.”.

Waud Capital合伙人Matthew Clary表示：“Waud Capital收购Science Exchange证明了他们的技术实力和领导团队的愿景。”。“这种合作关系结合了我们在软件、HCIT和制药服务方面的投资经验，完全符合我们在有吸引力的终端市场以差异化解决方案投资强大领导者的战略。”。

Paul Sutphin, Principal at Waud Capital, added, “It’s rare to find procurement software that customers rave about, and that’s what impressed us the most. Forward-thinking procurement leaders are leveraging Science Exchange’s subscription model and extensible cloud platform into increasingly complex parts of their organizations, driving significant time and cost savings which they can re-invest into R&D and drug development.”.

Waud Capital负责人Paul Sutphin补充道：“很少有客户对采购软件赞不绝口，这给我们留下了最深刻的印象。具有前瞻性的采购领导者正在利用Science Exchange的订阅模式和可扩展云平台，将其应用于其组织中日益复杂的部分，从而节省了大量时间和成本，可以将其重新投资于研发和药物开发。”。

Under Waud Capital’s ownership, Science Exchange plans to expand its product portfolio, invest in innovative technologies, and elevate its market presence to reinforce its standing as the premier SaaS supplier orchestration platform in the life sciences sector. Elizabeth Iorns, Ph.D, CEO & Co-Founder, along with Dan Knox, COO & Co-Founder, and Tzlil Hadass, Chief Revenue Officer, will retain their leadership roles, ensuring continuity for customers and stakeholders..

在Waud Capital的所有权下，科学交易所计划扩大其产品组合，投资创新技术，提高其市场占有率，以巩固其作为生命科学领域首屈一指的SaaS供应商协调平台的地位。。。

Mark Layden, Operating Partner at Waud Capital, will join the company as Executive Chairman. “I am incredibly excited to join Science Exchange at this pivotal moment in its growth journey,” said Mark. “Elizabeth and Dan have built an exceptional business with a truly innovative platform that is already transforming the life sciences sector.

Waud Capital的运营合伙人马克·莱登（MarkLayden）将加入该公司担任执行主席。马克说：“在科学交流的发展历程中的这一关键时刻，我非常高兴能加入科学交流。伊丽莎白和丹凭借一个真正创新的平台建立了一个非凡的业务，该平台已经在改变生命科学领域。

With Waud’s backing and the strength of this talented leadership team, I am confident that Science Exchange will continue to set the standard for supplier orchestration, driving even greater value for its customers and unlocking new opportunities for growth and innovation across the industry.”.

在Waud的支持和这支才华横溢的领导团队的力量下，我相信科学交易所将继续为供应商协调制定标准，为客户创造更大的价值，并为整个行业的增长和创新打开新的机会。”。

About Science Exchange

关于科学交流

Science Exchange is the first procurement and supplier orchestration cloud software platform for life sciences companies. The platform digitizes and streamlines complex procurement workflows spanning the entire purchasing lifecycle, from vendor and product discovery through purchasing and payment. Many of the world’s top pharma and biotech organizations rely on Science Exchange to help accelerate their research, automate manual processes, and advance their programs faster.

Science Exchange是生命科学公司的第一个采购和供应商协调云软件平台。该平台数字化并简化了从供应商和产品发现到采购和付款的整个采购生命周期的复杂采购工作流程。许多世界顶尖的制药和生物技术组织依靠科学交流来帮助加速其研究，自动化手动过程，并更快地推进其计划。

For additional information on Science Exchange, please visit www.scienceexchange.com..

有关科学交流的更多信息，请访问www.scienceexchange.com。。

About Waud Capital Partners

关于Waud Capital Partners

Based in Chicago, Waud Capital Partners is a growth-oriented private equity firm with over 30 years of investing experience. Waud Capital seeks to partner with experienced management teams to build market-leading companies within two industries: software & technology and healthcare. Since its founding in 1993, Waud Capital has completed more than 460 investments, including platform companies and follow-on opportunities.

Waud Capital Partners总部位于芝加哥，是一家以增长为导向的私人股本公司，拥有30多年的投资经验。Waud Capital寻求与经验丰富的管理团队合作，在软件与技术和医疗保健两个行业建立市场领先的公司。自1993年成立以来，Waud Capital已完成460多项投资，包括平台公司和后续机会。

For additional information on Waud Capital, please visit www.waudcapital.com..

有关Waud Capital的更多信息，请访问www.waudcapital.com。。